Komori
Terumo (4543) · PolicyAchieved

Non-speculative hedging of foreign exchange and interest rate fluctuation risk

First written in FY2016. 2 of 5 entries say "Restated". Latest entry: FY2024.

5entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019AdvancedFY2022 – FY20242016: 120162017: 120172018: 020182019: 120192020: 020202021: 020212022: 120222023: 020232024: 12024
Same theme, other companies
Hedging Policy for Derivatives Used Solely for Commercial ExposuresA theme 127 companies write about · 24 as a headwind · 92 as a tailwind

0 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 127 companies compared. The sentences above are computed from all 127.
Full recordFilings, disclosures and news, newest first
  1. FY2024AchievedAnnual report

    「For transactions applying cash flow hedge accounting, with borrowings referencing US dollar LIBOR designated as hedged items and interest rate and currency swaps designated as hedging instruments, the transition to alternative benchmark rates replacing LIBOR was completed during the consolidated fiscal year. Accordingly, at the end of the consolidated fiscal year, there were no financial instruments referencing LIBOR that had not transitioned to alternative benchmark rates.」

    As a response to the cessation of LIBOR, the transition to alternative benchmark rates was completed, leaving no LIBOR-referencing financial instruments that had not transitioned at the fiscal year-end.
  2. FY2022AdvancedAnnual report

    「Because the Group is affected by this reform of interest rate benchmarks, it is monitoring developments, assessing the impact and preparing to transition to alternative benchmark rates to replace LIBOR.」

    While continuing its policy of non-speculative interest rate and foreign exchange hedging, the Group proceeded with preparations to transition to alternative benchmark rates in response to the cessation of LIBOR. The notional principal of interest rate and currency swaps referencing US dollar LIBOR was ¥7,588.1 million.
  3. FY2019RestatedAnnual report

    「Under the Group's risk management policy, approximately 100% of the foreign exchange risk estimated for projected sales over the following 3 months is to be hedged at all times.」

    The policy of hedging foreign exchange and interest rate movements and not engaging in speculative transactions continues. The operating standard of hedging approximately 100% of the foreign exchange risk associated with projected sales over the following 3 months through forward foreign exchange contracts was specified.
  4. FY2017-Q3RestatedAnnual report

    「Foreign exchange and interest rate risks are hedged.」

    The policy of hedging foreign exchange and interest rate risks also continues to apply to borrowings used to fund acquisitions.
  5. FY2016First statedAnnual report

    「The policy is to use derivatives to mitigate interest rate and foreign exchange risks and not to enter into speculative transactions.」

    Forward foreign exchange contracts and interest rate swaps are used solely for risk mitigation, not for speculative purposes.
Moved together

"Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222222★123456
  1. ★This thread
  2. 1Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets2×
  3. 2Expanding market share in global markets and enhancing brand value2×
  4. 3Global sales expansion of cardiovascular products such as Ultimaster2×
  5. 4Sharing Interests with Shareholders Through Performance-Linked Compensation and Restricted Stock2×
  6. 5High-value-added products and services that contribute to reducing patients’ financial burden, improving medical safety, and enhancing operational efficiency2×
  7. 6Exploring New Growth Opportunities through Partnerships and M&A2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.